Mar 25, 2024

OICR-supported cancer therapeutics company Fusion Pharmaceuticals acquired by AstraZeneca for up to US $2.4 billion

Jan 29, 2024

Ask a cancer researcher: What are ‘imaging probes’ and how can they help diagnose prostate cancer?

Dec 02, 2020

Study uncovers new approach to mobilize the immune system against hard-to-treat breast cancers

Nov 18, 2019

Potential new approach to T-cell therapy shows early promise in the lab

Sep 30, 2019

Hamilton study discovers new approach to target cells at the root of leukemia

Sep 10, 2018

Researchers find unexpected cells at the centre of recurrent leukemia

Apr 09, 2018

Biostatistics Training Initiative boosts Ontario's cancer research community

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Oct 24, 2017

Researchers discover genes behind the spread of lung cancer to the brain

Oct 20, 2017

Old drug, new trick: study finds common diabetes drug could help fight leukemia

Oct 11, 2017

Ontario start-up makes major deal to develop cancer-fighting viruses

Aug 17, 2017

New genes discovered regulating brain metastases in lung cancer

Jul 04, 2016

OICR congratulates Drs. Mark Levine, Eduardo L. Franco and Gerald Batist, new recipients of the Order of Canada

Jun 01, 2016

Clinical trial launched to test use of MRI to improve prostate cancer diagnosis and management

May 05, 2016

A new method to grow stem cells for cancer patients

Mar 16, 2016

FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic

Feb 26, 2016

Biostatistics Training Initiative Kick Off

Dec 16, 2015

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics

Nov 09, 2015

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership